Prior to the phenotypic transformation of the malignant clone, it was shown that there was an increase in BCR-ABL1 mRNA expression in leukemia cells from patients with CP-CML who progressed to AP or BP [25]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.